A trial aiming to find a better treatment for multidrug-resistant tuberculosis (MDR-TB) has stopped enrolling patients early after its independent data safety and monitoring board indicated that the regimen being studied is superior to current care, and more patient data was extremely unlikely to...
On 14-15 April 2011 more than one hundred tuberculosis experts came together in Tashkent to discuss their experiences with and the challenges around scaling up tuberculosis (TB) care in the Central Asia region. In the end, everyone agreed: urgent action is needed. The symposium "Uniting to Scale up...
